Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Cancers|October 13, 2021
RBL1/p107 Expression Levels Are Modulated by Multiple Signaling PathwaysElisa Ventura, Carmelina Antonella Iannuzzi, Francesca Pentimalli, et al.Biochemical Pharmacology|April 25, 2020
Virotherapy: From single agents to combinatorial treatmentsAnna Maria Malfitano, Sarah Di Somma, Carmelina Antonella Iannuzzi, et al.Frontiers in Oncology|December 7, 2020
Triple-Negative Breast Cancer Comparison With Canine Mammary Tumors From Light Microscopy to Molecular PathologyAsadoor Amirkhani Namagerdi, Danila d'Angelo, Francesca Ciani, et al.International Journal of Oncology|May 14, 2019
Targeted therapy based on p53 reactivation reduces both glioblastoma cell growth and resistance to temozolomideIris Maria Forte, Paola Indovina, Carmelina Antonella Iannuzzi, et al.Journal of Cellular Physiology|December 16, 2019
Blood screening for heavy metals and organic pollutants in cancer patients exposed to toxic waste in southern Italy: A pilot studyIris Maria Forte, Paola Indovina, Aurora Costa, et al.International Journal of Molecular Sciences|September 13, 2025
NONO Protein Regulates the Immune Response in Human Triple-Negative Breast Cancer CellsCarmelina Antonella Iannuzzi, Iris Maria Forte, Marianna Tomeo, et al.International Journal of Molecular Sciences|October 6, 2020
Pharmacological Inhibition of WEE1 Potentiates the Antitumoral Effect of the <i>dl922-947</i> Oncolytic Virus in Malignant Mesothelioma Cell LinesCarmelina Antonella Iannuzzi, Paola Indovina, Iris Maria Forte, et al.The Science of the Total Environment|April 17, 2025
Biomonitoring of potentially toxic elements at two differentially anthropized areas of the "Land of Fires" (S Italy)Viviana Maresca, Alessia Postiglione, Antonietta Siciliano, et al.Cell Cycle (Georgetown, Tex.)|December 19, 2013
Pharmacological targeting of p53 through RITA is an effective antitumoral strategy for malignant pleural mesotheliomaDomenico Di Marzo, Iris Maria Forte, Paola Indovina, et al.Journal of Cellular Physiology|April 3, 2016
SRC Family Kinase Inhibition in Ewing Sarcoma Cells Induces p38 MAP Kinase-Mediated Cytotoxicity and Reduces Cell MigrationPaola Indovina, Nadia Casini, Iris Maria Forte, et al.Pageof 3